Definitive Forensic Pathology for Criminal and Civil LitigationBridging Medicine and Law through forensic Pathology
|
Our ExpertDr. Robin has directed anatomic, clinical, and specialty laboratories in hospital and commercial settings for the past 44 years. He was Chairman of the Pathology Department at Sharp Memorial Hospital in San Diego, California. Dr. Robin has performed over 2500 forensic and medical autopsies. Dr. Robin is an immunopathologist interested in clinical chemistry, molecular diagnostics, infectious diseases, cancer diagnostics, and immune-mediated diseases.
He received his M.D. degree and residency training in anatomic and clinical pathology at Jefferson Medical School. He was a research fellow in Molecular Immunology at Scripps Clinic and Research Foundation and is board-certified in Anatomic and Clinical Pathology and Immunopathology. Dr. Robin is a Fellow of the College of American Pathologists, the American Association of Clinical Chemists, the American Medical Association, and the California Society of Pathologists. |
Curriculum Vitae • Howard S. Robin, M.D.
EDUCATION
Central High School, Philadelphia, Pennsylvania, B.A.
Pennsylvania State University, University Park, Pennsylvania, B.S.
Jefferson Medical College, Philadelphia, Pennsylvania, M.D., Cum Laude.
POSTDOCTORAL TRAINING
Chestnut Hill Hospital, Philadelphia, Pennsylvania, Rotating Internship.
Thomas Jefferson University, Philadelphia, Pennsylvania, Resident Anatomic and Clinical Pathology.
Scripps Clinic and Research Foundation Department of Molecular Immunology,
La Jolla, California, Research Fellow.
LICENSURE AND CERTIFICATION
California State Medical License
Anatomic and Clinical Pathology, Board Certified
Immunopathology, Board Certified
CURRENT POSITIONS
Pathologist Consultant, Crown Bioscience, January 2015 to Present. Review human cancer models to determine efficacy and safety of cancer drugs.
Medical Advisor Luminoma, November 2023 to present. Provide medical advice for the evaluation of skin cancers using a non-invasive instrument.
Medical Advisor Genovo Molecular Diagnostics, January 2017 to present. Precision Medicine Laboratory specializing in targeted therapies for cancer and metabolic disorders.
Medical Advisor New Zealand Technology and Trade Association, December 2016 to present. Private sector advisor acting as a mentor to provide insights into growing an internationally successful business.
Inspector, College of American Pathologists, 1988 to present. Inspect CAP-accredited laboratories.
Consultant Kaufman Associates, December 2014 to present. Advisor on compensation and contracting for hospital-based physicians.
FORENSIC EXPERIENCE
For over four decades, I have been a trusted forensic pathology expert witness in a wide range of legal proceedings, including medical malpractice, product liability, civil litigation, and criminal cases. As a seasoned forensic pathologist, I provide authoritative consultations and testimony for both plaintiff and defense attorneys. My expertise spans the critical intersections of medicine and law, with deep knowledge in the areas of pharmacology, toxicology, autopsy pathology, and clinical laboratory medicine. I bring unique insights in cancer diagnosis, prognosis, and treatment that can be pivotal in complex medical-legal cases.
PAST POSITIONS
Progenity, Principal Investigator, October 2015 to February 2022. Gastric capsule device safety study. Developing novel drug therapies for NAFLD.
NeorahDX, Chief Medical Officer, 2020 to June 2021, Molecular Diagnostics focused on infectious diseases.
Medical Director AristaMD, October 2017 to April 2019. eHealth Solutions for Primary Care Physician Referrals.
Medical Advisor, Phagetech LLC, December 2014 to December 2017. Principal investigator for biomedical device utilizing bacteriophage and electro-conductance to detect bladder cancer biomarkers in urine.
Laboratory Director BioArkive, May 2020 to January 2022. Biorepository and preclinical laboratory performing cold storage biobanking and laboratory services for pharmaceutical clients.
CLINICAL LABORATORY EXPERIENCE
Laboratory Position held Years in position
National Health Labs San Diego / Medical Director 1977 to 1982
National Health Labs Pasadena / Medical Director 1977 to 1982
Diagnostic Immunology Lab Orange / Medical Director 1979 to 1981
Cabrillo Medical Center San Diego / Medical Director 1976 to 1981
Sharp Cabrillo Hospital San Diego / Medical Director 1981 to 1994
Sharp Memorial Hospital San Diego / Medical Director 1994 to 2009
Pacific Rim Pathology Lab / President 1995 to 2009
Genoptix / Medical Director 2002 to 2004
Sharp Rees Stealy Labs / Medical Director 2000 to 2008
Sequenom Center Molecular Medicine / Medical Director 2010 to 2011
Pediatric Bioscience / Medical Director 2011 to 2014
Molecular Response Lab / Medical Director 2013 to 2014
Genalyte Clinical Laboratory / Medical Director 2015 to 2016
MEMBERSHIPS IN SOCIETIES
Fellow, College of American Pathologists, 1980 to present
Member, Association for Diagnostics & Laboratory Medicine, 2001 to present
Member, California Society of Pathologists, 1995 to present
Member, American Medical Association, 2010 to present.
MAJOR RESEARCH INTERESTS
Cancer, molecular and proteomic technologies, diagnosis, and targeted therapies
Melanoma, molecular diagnosis
Prostate cancer, molecular markers for prognosis and prediction of outcome
Breast cancer, molecular markers for prognosis and prediction of outcome
Liver disease, including NAFLD, and hepatitis virus infections.
Hepatitis C Virus, molecular biology, serology and histopathology
Renal disease, histopathology, immunopathology, and ultrastructural findings
Laboratory-developed tests and laboratory accreditation.
Toxicology and pharmacology of drugs of abuse
Transfusion medicine, indications, risks, and benefits
BOARD ACTIVITIES
Board of Directors, Sharp Health Care Foundation, December 2006 to January 2016
Advisory Board, City National Bank, 2006 to 2021.
President, Board of Directors, San Diego Blood Bank, January 2008 to December 2009
President, Board of Directors, Pacific Rim Pathology, June 1994 to May 2009
Board of Trustees, San Diego Hospital Association, July 1990 to July 1992
Board of Trustees - Sharp Cabrillo Hospital, July 1987 to July 1992
Board of Directors - American Cancer Society, San Diego Unit, January 1984 to 1991
Board of Directors - American Cancer Society, California Division, September 1986 to 1987
PREVIOUS APPOINTMENTS
Medical Director Continuing Medical Education, Sharp Health Care, 1993 to December 2013.
Secretary-Treasurer, Medical Executive Committee, Sharp Memorial Hospital, January 2008 to December 2009.
Medical Director Laboratory Services, Sharp Memorial Hospitals, May 1994 to December 2009
Chairman Pathology Department, Sharp Memorial Hospital, 1994 to 2002, and 2008 to 2009
Director, Blood Bank, Sharp Memorial Hospital, January 1982 to December 2007
Chairman, Pharmacy & Therapeutics Committee, Sharp Memorial Hospital, 1994 to December 2009
Quality Assurance Committee, Sharp Memorial Hospital, 1989 to 2011
Member Executive Medical Board, Sharp Memorial Hospital, 1992 to 2002 and 2008 to 2009
Executive Medical Committee, Sharp Cabrillo Hospital, July 1984 to July 1995
Chief of Medicine, Sharp Cabrillo Hospital, San Diego, California, July 1984 to July 1988
Chief of Staff, Sharp Cabrillo Hospital, San Diego, California July 1990 to July 1992
AWARDS AND HONORS
Alpha Omega Alpha, Jefferson Chapter, Philadelphia, Pennsylvania, 1970
Mosby Scholarship Book Award, 1971
William C. Felch Award, Alliance Continuing Medical Education, 1991
Golden Staff Award Sharp Cabrillo Hospital, 1994
Physician Recognition Award by Peers, San Diego Magazine, 2004 and 2008
OTHER PROFESSIONAL APPOINTMENTS
Pathologist, Coroner’s Office, San Diego County, September 1978 to June 1982
Chairman, Professional Education Committee, American Cancer Society, San Diego Unit, January 1984 to September 1985
Chairman, Professional Education Committee, American Cancer Society, California Division, Area III, May 1986 to May 1987
President, American Cancer Society, San Diego Unit, September 1988 to September 1989
Chairman, Public Issues Committee, California Division, American Cancer Society, September 1989 to August 1990
Vice President for Community Services, American Cancer Society, San Diego Unit, September 1990 to August 1991
BIBLIOGRAPHY
Books
1. Robin, H.S., Michelson, J.B.: Atlas of Medical Complications of Drug Abuse. Yearbook Publisher, 1988
Book Chapters
1. Michelson, J.B., Robin, H.S., Nosik, R.E.: Nonocular Manifestations of Parenteral Drug Abuse; Seminars in Ophthalmology May 1986.
2. Robin, H.S., Immunologic Aspects of AIDS. In: Kolins, J. and Metinkoff, J. ed's. Acquired Immune Deficiency Syndrome, Washington, D.C., AABB Publishers, 1986.
Articles
1. Rajesh Kumari, Ji Won Lim, Matthew Ryan Sullivan, Rachel Malampy, Connor Baush, Irina Smolina, Howard Robin, Vadim V. Demidov 5, Giovanni Stefano Ugolini, Jared R. Auclair and Tania Konry. A Novel Rolling Circle Amplification-Based Detection of SARS-CoV-2 with Multi-Region Padlock Hybridization. Diagnostics: September 11, 2022.
2. Gerami P, Alsobrook JP, Palmer TJ, Robin HS.
Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin. J Am Acad Dermatol. 2014 Aug;71(2):237-44. doi: 10.1016/j.jaad.2014.04.042. Epub 2014 Jun 4.
3. Vener T, Derecho C, Baden J, Wang H, Rajpurohit Y, Skelton J, Mehrotra J, Varde S, Chowdary D, Stallings W, Leibovich B,Robin H, Pelzer A, Schäfer G, Auprich M, Mannweiler S, Amersdorfer P, Mazumder A. Development of a multiplexed urine assay for prostate cancer diagnosis. Clin Chem. 2008 May;54(5):874-82. doi: 10.1373/clinchem.2007.094912. Epub 2008 Mar 13.
4. Ma XJ, Patel R, Wang X, Salunga R, Murage J, Desai R, Tuggle JT, Wang W, Chu S, Stecker K, Raja R, Robin H, Moore M, Baunoch D, Sgroi D, Erlander M. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay.
Arch Pathol Lab Med. 2006 Apr;130(4):465-73.
5. Overstreet K, Barone RM, Robin HS. Secondary amyloidosis and gastrointestinal stromal tumors. A case report and discussion of pathogenesis.
Arch Pathol Lab Med. 2003 Apr;127(4):470-3.
6. Kawakami M, Kawakami K, Stepensky VA, Maki RA, Robin H, Muller W, Husain SR, Puri RK. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
Clin Cancer Res. 2002 Nov;8(11):3503-11.
7. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy.
Am J Dermatopathol. 2001 Oct;23(5):383-93.
8. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.
Lancet. 2000 Sep 16;356(9234):1000-1.
9. Pronovost AD, Rose SL, Pawlak JW, Robin H, Schneider R. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results.
J Clin Microbiol. 1994 Jan;32(1):46-50.
10. Travis WD, Kalafer ME, Robin HS, Luibel FJ. Hypersensitivity pneumonitis and pulmonary vasculitis with eosinophilia in a patient taking an L-tryptophan preparation.
Ann Intern Med. 1990 Feb 15;112(4):301-3.
11. Ho DD, Moudgil T, Robin HS, Alam M, Wallace BJ, Mizrachi Y. Human immunodeficiency virus type 1 in a seronegative patient with visceral Kaposi's sarcoma and hypogammaglobulinemia.
Am J Med. 1989 Mar;86(3):349-51.
12. Gresham LS, Molgaard CA, Elder JP, Robin HS. Breast cancer and mammography: summary of the educational impact of a low-cost mammography program.
Health Educ. 1988 Jun-Jul;19(3):32-5.
13. Michelson JB, Robin HS, Nozik RA. Nonocular manifestations of parenteral drug abuse.
Surv Ophthalmol. 1986 Mar-Apr;30(5):314-20.
14. Robin HS, Barnhart F, Shaw R, Raasch F. Hepatitis B and the coroner's office.
Am J Forensic Med Pathol. 1982 Sep;3(3):281-2.
Abstracts
Central High School, Philadelphia, Pennsylvania, B.A.
Pennsylvania State University, University Park, Pennsylvania, B.S.
Jefferson Medical College, Philadelphia, Pennsylvania, M.D., Cum Laude.
POSTDOCTORAL TRAINING
Chestnut Hill Hospital, Philadelphia, Pennsylvania, Rotating Internship.
Thomas Jefferson University, Philadelphia, Pennsylvania, Resident Anatomic and Clinical Pathology.
Scripps Clinic and Research Foundation Department of Molecular Immunology,
La Jolla, California, Research Fellow.
LICENSURE AND CERTIFICATION
California State Medical License
Anatomic and Clinical Pathology, Board Certified
Immunopathology, Board Certified
CURRENT POSITIONS
Pathologist Consultant, Crown Bioscience, January 2015 to Present. Review human cancer models to determine efficacy and safety of cancer drugs.
Medical Advisor Luminoma, November 2023 to present. Provide medical advice for the evaluation of skin cancers using a non-invasive instrument.
Medical Advisor Genovo Molecular Diagnostics, January 2017 to present. Precision Medicine Laboratory specializing in targeted therapies for cancer and metabolic disorders.
Medical Advisor New Zealand Technology and Trade Association, December 2016 to present. Private sector advisor acting as a mentor to provide insights into growing an internationally successful business.
Inspector, College of American Pathologists, 1988 to present. Inspect CAP-accredited laboratories.
Consultant Kaufman Associates, December 2014 to present. Advisor on compensation and contracting for hospital-based physicians.
FORENSIC EXPERIENCE
For over four decades, I have been a trusted forensic pathology expert witness in a wide range of legal proceedings, including medical malpractice, product liability, civil litigation, and criminal cases. As a seasoned forensic pathologist, I provide authoritative consultations and testimony for both plaintiff and defense attorneys. My expertise spans the critical intersections of medicine and law, with deep knowledge in the areas of pharmacology, toxicology, autopsy pathology, and clinical laboratory medicine. I bring unique insights in cancer diagnosis, prognosis, and treatment that can be pivotal in complex medical-legal cases.
PAST POSITIONS
Progenity, Principal Investigator, October 2015 to February 2022. Gastric capsule device safety study. Developing novel drug therapies for NAFLD.
NeorahDX, Chief Medical Officer, 2020 to June 2021, Molecular Diagnostics focused on infectious diseases.
Medical Director AristaMD, October 2017 to April 2019. eHealth Solutions for Primary Care Physician Referrals.
Medical Advisor, Phagetech LLC, December 2014 to December 2017. Principal investigator for biomedical device utilizing bacteriophage and electro-conductance to detect bladder cancer biomarkers in urine.
Laboratory Director BioArkive, May 2020 to January 2022. Biorepository and preclinical laboratory performing cold storage biobanking and laboratory services for pharmaceutical clients.
CLINICAL LABORATORY EXPERIENCE
Laboratory Position held Years in position
National Health Labs San Diego / Medical Director 1977 to 1982
National Health Labs Pasadena / Medical Director 1977 to 1982
Diagnostic Immunology Lab Orange / Medical Director 1979 to 1981
Cabrillo Medical Center San Diego / Medical Director 1976 to 1981
Sharp Cabrillo Hospital San Diego / Medical Director 1981 to 1994
Sharp Memorial Hospital San Diego / Medical Director 1994 to 2009
Pacific Rim Pathology Lab / President 1995 to 2009
Genoptix / Medical Director 2002 to 2004
Sharp Rees Stealy Labs / Medical Director 2000 to 2008
Sequenom Center Molecular Medicine / Medical Director 2010 to 2011
Pediatric Bioscience / Medical Director 2011 to 2014
Molecular Response Lab / Medical Director 2013 to 2014
Genalyte Clinical Laboratory / Medical Director 2015 to 2016
MEMBERSHIPS IN SOCIETIES
Fellow, College of American Pathologists, 1980 to present
Member, Association for Diagnostics & Laboratory Medicine, 2001 to present
Member, California Society of Pathologists, 1995 to present
Member, American Medical Association, 2010 to present.
MAJOR RESEARCH INTERESTS
Cancer, molecular and proteomic technologies, diagnosis, and targeted therapies
Melanoma, molecular diagnosis
Prostate cancer, molecular markers for prognosis and prediction of outcome
Breast cancer, molecular markers for prognosis and prediction of outcome
Liver disease, including NAFLD, and hepatitis virus infections.
Hepatitis C Virus, molecular biology, serology and histopathology
Renal disease, histopathology, immunopathology, and ultrastructural findings
Laboratory-developed tests and laboratory accreditation.
Toxicology and pharmacology of drugs of abuse
Transfusion medicine, indications, risks, and benefits
BOARD ACTIVITIES
Board of Directors, Sharp Health Care Foundation, December 2006 to January 2016
Advisory Board, City National Bank, 2006 to 2021.
President, Board of Directors, San Diego Blood Bank, January 2008 to December 2009
President, Board of Directors, Pacific Rim Pathology, June 1994 to May 2009
Board of Trustees, San Diego Hospital Association, July 1990 to July 1992
Board of Trustees - Sharp Cabrillo Hospital, July 1987 to July 1992
Board of Directors - American Cancer Society, San Diego Unit, January 1984 to 1991
Board of Directors - American Cancer Society, California Division, September 1986 to 1987
PREVIOUS APPOINTMENTS
Medical Director Continuing Medical Education, Sharp Health Care, 1993 to December 2013.
Secretary-Treasurer, Medical Executive Committee, Sharp Memorial Hospital, January 2008 to December 2009.
Medical Director Laboratory Services, Sharp Memorial Hospitals, May 1994 to December 2009
Chairman Pathology Department, Sharp Memorial Hospital, 1994 to 2002, and 2008 to 2009
Director, Blood Bank, Sharp Memorial Hospital, January 1982 to December 2007
Chairman, Pharmacy & Therapeutics Committee, Sharp Memorial Hospital, 1994 to December 2009
Quality Assurance Committee, Sharp Memorial Hospital, 1989 to 2011
Member Executive Medical Board, Sharp Memorial Hospital, 1992 to 2002 and 2008 to 2009
Executive Medical Committee, Sharp Cabrillo Hospital, July 1984 to July 1995
Chief of Medicine, Sharp Cabrillo Hospital, San Diego, California, July 1984 to July 1988
Chief of Staff, Sharp Cabrillo Hospital, San Diego, California July 1990 to July 1992
AWARDS AND HONORS
Alpha Omega Alpha, Jefferson Chapter, Philadelphia, Pennsylvania, 1970
Mosby Scholarship Book Award, 1971
William C. Felch Award, Alliance Continuing Medical Education, 1991
Golden Staff Award Sharp Cabrillo Hospital, 1994
Physician Recognition Award by Peers, San Diego Magazine, 2004 and 2008
OTHER PROFESSIONAL APPOINTMENTS
Pathologist, Coroner’s Office, San Diego County, September 1978 to June 1982
Chairman, Professional Education Committee, American Cancer Society, San Diego Unit, January 1984 to September 1985
Chairman, Professional Education Committee, American Cancer Society, California Division, Area III, May 1986 to May 1987
President, American Cancer Society, San Diego Unit, September 1988 to September 1989
Chairman, Public Issues Committee, California Division, American Cancer Society, September 1989 to August 1990
Vice President for Community Services, American Cancer Society, San Diego Unit, September 1990 to August 1991
BIBLIOGRAPHY
Books
1. Robin, H.S., Michelson, J.B.: Atlas of Medical Complications of Drug Abuse. Yearbook Publisher, 1988
Book Chapters
1. Michelson, J.B., Robin, H.S., Nosik, R.E.: Nonocular Manifestations of Parenteral Drug Abuse; Seminars in Ophthalmology May 1986.
2. Robin, H.S., Immunologic Aspects of AIDS. In: Kolins, J. and Metinkoff, J. ed's. Acquired Immune Deficiency Syndrome, Washington, D.C., AABB Publishers, 1986.
Articles
1. Rajesh Kumari, Ji Won Lim, Matthew Ryan Sullivan, Rachel Malampy, Connor Baush, Irina Smolina, Howard Robin, Vadim V. Demidov 5, Giovanni Stefano Ugolini, Jared R. Auclair and Tania Konry. A Novel Rolling Circle Amplification-Based Detection of SARS-CoV-2 with Multi-Region Padlock Hybridization. Diagnostics: September 11, 2022.
2. Gerami P, Alsobrook JP, Palmer TJ, Robin HS.
Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin. J Am Acad Dermatol. 2014 Aug;71(2):237-44. doi: 10.1016/j.jaad.2014.04.042. Epub 2014 Jun 4.
3. Vener T, Derecho C, Baden J, Wang H, Rajpurohit Y, Skelton J, Mehrotra J, Varde S, Chowdary D, Stallings W, Leibovich B,Robin H, Pelzer A, Schäfer G, Auprich M, Mannweiler S, Amersdorfer P, Mazumder A. Development of a multiplexed urine assay for prostate cancer diagnosis. Clin Chem. 2008 May;54(5):874-82. doi: 10.1373/clinchem.2007.094912. Epub 2008 Mar 13.
4. Ma XJ, Patel R, Wang X, Salunga R, Murage J, Desai R, Tuggle JT, Wang W, Chu S, Stecker K, Raja R, Robin H, Moore M, Baunoch D, Sgroi D, Erlander M. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay.
Arch Pathol Lab Med. 2006 Apr;130(4):465-73.
5. Overstreet K, Barone RM, Robin HS. Secondary amyloidosis and gastrointestinal stromal tumors. A case report and discussion of pathogenesis.
Arch Pathol Lab Med. 2003 Apr;127(4):470-3.
6. Kawakami M, Kawakami K, Stepensky VA, Maki RA, Robin H, Muller W, Husain SR, Puri RK. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
Clin Cancer Res. 2002 Nov;8(11):3503-11.
7. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy.
Am J Dermatopathol. 2001 Oct;23(5):383-93.
8. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.
Lancet. 2000 Sep 16;356(9234):1000-1.
9. Pronovost AD, Rose SL, Pawlak JW, Robin H, Schneider R. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results.
J Clin Microbiol. 1994 Jan;32(1):46-50.
10. Travis WD, Kalafer ME, Robin HS, Luibel FJ. Hypersensitivity pneumonitis and pulmonary vasculitis with eosinophilia in a patient taking an L-tryptophan preparation.
Ann Intern Med. 1990 Feb 15;112(4):301-3.
11. Ho DD, Moudgil T, Robin HS, Alam M, Wallace BJ, Mizrachi Y. Human immunodeficiency virus type 1 in a seronegative patient with visceral Kaposi's sarcoma and hypogammaglobulinemia.
Am J Med. 1989 Mar;86(3):349-51.
12. Gresham LS, Molgaard CA, Elder JP, Robin HS. Breast cancer and mammography: summary of the educational impact of a low-cost mammography program.
Health Educ. 1988 Jun-Jul;19(3):32-5.
13. Michelson JB, Robin HS, Nozik RA. Nonocular manifestations of parenteral drug abuse.
Surv Ophthalmol. 1986 Mar-Apr;30(5):314-20.
14. Robin HS, Barnhart F, Shaw R, Raasch F. Hepatitis B and the coroner's office.
Am J Forensic Med Pathol. 1982 Sep;3(3):281-2.
Abstracts
- Robin, H.S.: Structural Independence of LDL-In Receptor from Fc, SIg, C3b, C3d, and E rosette Receptors. Fed. Proc. 36:1235, 1977.
- Robin, H.S., Myers, B., Pileggi, V., Winkelman, J.: Simultaneous Detection of HBsAg/Anti-HBs by a Combination Solid-Phase Sandwich and Sequential Competitive Binding Assay. Abstract presented at the Annual Meeting of Academy of Clinical Laboratory Physicians and Scientists, May, 1978.
- B. Martin, Robin, H.S., R. Williams, W. Ornelas: Neonatal Graft Versus Host Disease Following Transfusion of Maternal Platelets. AABB November 1984.
- Wormsley, S., Robin, H.S., A. Cohen, P. Goldfarb: Flow Cytometry of Body Fluids. International Conference of Analytical Cytology, November 1985.
- Robin, H.S., Wormsley, S., A. Raney, D. Zusman, J. Peter: Immunologic Monitoring Of Heart Transplant Patients By Flow Cytometry. AABB, November 1986.
- Wormsley, S.B., and Robin, H.S.: Characterization of Breast Carcinoma by Flow Cytometry; 2nd International Workshop on Monoclonal Antibodies and Breast Cancer, November 1986.
- B. Myers, T. Stern; Behring Diagnostics, La Jolla, CA and H. Robin, Sharp Cabrillo Hospital, San Diego, CA. Antibody to Hepatitis B Core Antigen as a Diagnostic and Prognostic Marker for Hepatitis B Viral Infection. ASM Annual Meeting, Atlanta, GA. March, 1987.
- S.B. Wormsley, H.S. Robin, A.A. Raney, D.R. Zusman, B.E. Jaski, S.C. Smith, J.W. Bonar, J.B. Stewart, J.B. Peter; Flow Cytometric Immune Monitoring (FCIM) for Prediction of Rejection, Infection and Lymphoproliferative Disorders in Cardiac Allograft Recipients. International Society for Heart Transplantation, Seventh Annual Scientific Sessions, March 1987, New Orleans, LA.
- A.A. Raney, S.B. Wormsley, H.S. Robin, D.R. Zusman, B.E. Jaski, S.C. Smith, J.W. Bonar, J.B. Stewart, J.B. Peter; Flow Cytometric Immune Monitoring (FCIM) As and Indicator for the Timing of Endomyocardial Biopsy. International Society for Heart Transplantation, Seventh Annual Scientific Sessions, March 1987, New Orleans, LA.
- Wormsley, S.B; Robin, H.S.; Adamson, R.M.; Dembitsky, Wp. P.; Daily, P.O.; Raney, A.A.; Zusman, D.R.; Jaski, B.E.; Smith, S.C.; Hoagland, P.; Bonar, J.W.; Stewart, J.B.; Saiget, S.; Grover, T.L.; Coburn, J.A. Immunologic Recognition of Rejection. First Canadian Conference on Cardiac Transplantation, May 1988.
- Robin, HS., Eberhardt, JS., Gaertner, R., Armstrong, M. Application of multivariate probabilistic (Bayesian) networks to the interpretation of diagnostic assays. May 2005.
- Wu L, Robin HS, Gallarda JL, Eberhardt JS, Muller WD, Sadeghi S, Clark RC. Prognostic value of p53 specific mutations in low-risk HER-2/neu negative primary breast cancers. December 2005.
- Jack Groskopf1, Siobhan Miick1, Chris Wixom2, Alexis Parton2, Mark Reynolds1, Harry Rittenhouse1, Howard Robin2, and Mahul B. Amin3. Direct Detection of TMPRSS2: ETS Family Gene Fusion mRNAs in Prostatectomy Tissue: Prevalence and Correlation with Clinicopathologic Data.
- Anthony. L. James1, Zephyr Fors1, Siobhan Miick1, Alexis N. Parton2, Howard S. Robin2,
- Harry Rittenhouse1 and Jack Groskopf1. Quantitation of PSA mRNA from FFPE prostate tissue: specific mRNA extraction, transcription-mediated amplification and detection in ~6 hours.
- Siobhan M. Miick1, Zephyr Fors1, Anthony N. James1, Chris Wixom2, Priya Nigwekar3,
- Ghee Young Kwon3, Yousef E. Tadros3, Ruta Gupta3, Alexis N. Parton2, Mark Reynolds1,
- Harry Rittenhouse1, Howard S. Robin2, and Mahul B. Amin3, Jack Groskopf1. Detection of mRNA fusion transcripts of TMPRSS2: ETS family chromosomal rearrangements in radical prostatectomy tissue from 100 cases.
- Siobhan M. Miick1, Zephyr Fors1, Anthony James1, Mark Reynolds1, Chris Wixom2, Priya Negwakar3, Ghee Young Kwon3, Alexis Parton2, Harry Rittenhouse1, Howard S. Robin2, and Mahul B. Amin3, Jack Groskopf1. Morphologic Correlates of Individual splice variants of TMPRRS2: ETS family prostate Cancer (PCA) detected by Transcription-mediated amplification (TMA) in Radical Prostatectomy Specimens.
- Siobhan M. Miick1, Zephyr Fors1, Anthony James1, Mark Reynolds1, Chris Wixom2, Priya Negwakar3, Ghee Young Kwon3, Alexis Parton2, Harry Rittenhouse1, Howard S. Robin2 and Mahul B. Amin3, Jack Groskopf1. Detection of mRNA fusion Transcripts of TMPRSS2: ETS family. Chromosomal Rearrangements in Prostate Cancer measured in Radical Prostatectomy Tissue from 100 Cases.
- S. Miick1, GY Kwon2, C Wixom3, P Nigwekar2, Y Tadros2, R Gupta2, H Robin3, MB Amin2, H Rittenhouse1, J Groskopf1. Direct detection of TMPRSS2: ETS family Gene Fusion mRNAs in Prostatectomy Tissue: Prevalence and Correlation with Clinicopathologic Data.
- Groskopf J., Miick S., Kwon G.Y., Wixom C., Nigwekar P., Tadros Y., Gupta R., Robin H.S., Rittenhouse H., Amin M.B. Direct detection of tmprss2:ets gene fusion mRNAs in prostatectomy tissue: prevalence and correlation with pathologic features page . 2008 European Association of Urology. Published by Elsevier B.V 141.
- S. Miick, P. S. Nigwekar, H. Rittenhouse, J. Groskopf, G. Kwon, Y. E. Tadros, R. Gupta, H. S. Robin, M. B. Amin. Morphologic correlates of individual splice variants of TMPRSS2:Etsfamily prostate cancer (PCa) detected by transcription-mediated amplification (TMA) in radical prostatectomy specimens.
- H.Robin, T. Palmer, J. Alsobrook. Reproducibility and Accuracy of RTQPCR Testing Cross Platform for the Detection of mRNA from Surface Squamous Cells Overlying Pigmented Skin Lesions. Association Molecular Pathology Annual Meeting November 2013.